Divya Awasthi

1.0k total citations
21 papers, 785 citations indexed

About

Divya Awasthi is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Divya Awasthi has authored 21 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Infectious Diseases and 7 papers in Epidemiology. Recurrent topics in Divya Awasthi's work include Tuberculosis Research and Epidemiology (12 papers), Cancer therapeutics and mechanisms (9 papers) and Bacterial Genetics and Biotechnology (5 papers). Divya Awasthi is often cited by papers focused on Tuberculosis Research and Epidemiology (12 papers), Cancer therapeutics and mechanisms (9 papers) and Bacterial Genetics and Biotechnology (5 papers). Divya Awasthi collaborates with scholars based in United States, India and France. Divya Awasthi's co-authors include Iwao Ojima, Kunal Kumar, Richard A. Slayden, Susan E. Knudson, Peter J. Tonge, Seung-Yub Lee, Joel S. Freundlich, Bela Ruzsicska, Ilaria Zanardi and William T. Berger and has published in prestigious journals such as PLoS ONE, Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Divya Awasthi

20 papers receiving 773 citations

Peers

Divya Awasthi

GENET

EPIDE

Lynn Miesel United States

Victoria Jones United States

John N. Alumasa United States

Tanjore S. Balganesh India

Miha Kotnik Slovenia

Giulia Degiacomi Italy

Curtis A. Engelhart United States

Paul Falk United States

Nathalie Barilone France

Jiuyu Liu United States

Lynn Miesel United States

Divya Awasthi

440 ×1.0

307 ×1.0

109 ×0.4

125 ×0.8

GENET

203 ×1.5

EPIDE

Citations per year, relative to Divya Awasthi Divya Awasthi (= 1×) peers Lynn Miesel

Countries citing papers authored by Divya Awasthi

Since Specialization

Citations

This map shows the geographic impact of Divya Awasthi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Divya Awasthi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Divya Awasthi more than expected).

Fields of papers citing papers by Divya Awasthi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Divya Awasthi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Divya Awasthi. The network helps show where Divya Awasthi may publish in the future.

Co-authorship network of co-authors of Divya Awasthi

This figure shows the co-authorship network connecting the top 25 collaborators of Divya Awasthi. A scholar is included among the top collaborators of Divya Awasthi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Divya Awasthi. Divya Awasthi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Manning, Alyssa J., et al.. (2022). Identification of Novel Chemical Scaffolds that Inhibit the Growth of Mycobacterium tuberculosis in Macrophages. Frontiers in Pharmacology. 12. 790583–790583. 10 indexed citations

Manning, Alyssa J., Divya Awasthi, Yulia Ovechkina, et al.. (2022). Chemical Exploration of a Highly Selective Scaffold with Activity against Intracellular Mycobacterium tuberculosis. Microbiology Spectrum. 10(3). e0116122–e0116122. 1 indexed citations

Gupta, Parikshaa, et al.. (2021). Malignant uterine perivascular epithelioid cell tumor: histopathologic and immunohistochemical characterization of a rare tumor in a post-menopausal woman.. PubMed. 14(9). 993–999. 2 indexed citations

Jakoncic, Jean, et al.. (2019). Novel T9 loop conformation of filamenting temperature-sensitive mutant Z from Mycobacterium tuberculosis. Acta Crystallographica Section F Structural Biology Communications. 75(5). 359–367.

McNeil, Matthew B., Somsundaram Chettiar, Divya Awasthi, & Tanya Parish. (2019). Cell wall inhibitors increase the accumulation of rifampicin in Mycobacterium tuberculosis. Access Microbiology. 1(1). e000006–e000006. 14 indexed citations

Manning, Alyssa J., et al.. (2018). High content, high-throughput screening for small molecule inducers of NF-κB translocation. PLoS ONE. 13(6). e0199966–e0199966. 10 indexed citations

Awasthi, Divya & Joel S. Freundlich. (2017). Antimycobacterial Metabolism: Illuminating Mycobacterium tuberculosis Biology and Drug Discovery. Trends in Microbiology. 25(9). 756–767. 27 indexed citations

Berube, Bryan J., Gauri Shetye, Somsundaram Chettiar, et al.. (2017). Improved Phenoxyalkylbenzimidazoles with Activity against Mycobacterium tuberculosis Appear to Target QcrB. ACS Infectious Diseases. 3(12). 898–916. 49 indexed citations

Kumar, Pradeep, Nisha Mittal, Shao-Gang Li, et al.. (2017). A Novel Small-Molecule Inhibitor of the Mycobacterium tuberculosis Demethylmenaquinone Methyltransferase MenG Is Bactericidal to Both Growing and Nutritionally Deprived Persister Cells. mBio. 8(1). 62 indexed citations

10.

Ojima, Iwao, et al.. (2016). Strategic incorporation of fluorine in the drug discovery of new-generation antitubercular agents targeting bacterial cell division protein FtsZ. Journal of Fluorine Chemistry. 196. 44–56. 13 indexed citations

11.

Knudson, Susan E., Divya Awasthi, Kunal Kumar, et al.. (2015). Cell division inhibitors with efficacy equivalent to isoniazid in the acute murineMycobacterium tuberculosisinfection model. Journal of Antimicrobial Chemotherapy. 70(11). 3070–3073. 21 indexed citations

12.

Knudson, Susan E., Kunal Kumar, Divya Awasthi, Iwao Ojima, & Richard A. Slayden. (2014). In vitro–in vivo activity relationship of substituted benzimidazole cell division inhibitors with activity against Mycobacterium tuberculosis. Tuberculosis. 94(3). 271–276. 25 indexed citations

13.

Ojima, Iwao, et al.. (2014). Drug discovery targeting cell division proteins, microtubules and FtsZ. Bioorganic & Medicinal Chemistry. 22(18). 5060–5077. 60 indexed citations

14.

Park, Bora, Divya Awasthi, Kunal Kumar, et al.. (2014). Design, synthesis and evaluation of novel 2,5,6-trisubstituted benzimidazoles targeting FtsZ as antitubercular agents. Bioorganic & Medicinal Chemistry. 22(9). 2602–2612. 53 indexed citations

15.

Knudson, Susan E., Divya Awasthi, Kunal Kumar, et al.. (2014). A Trisubstituted Benzimidazole Cell Division Inhibitor with Efficacy against Mycobacterium tuberculosis. PLoS ONE. 9(4). e93953–e93953. 20 indexed citations

16.

Kumar, Kunal, Divya Awasthi, Seung-Yub Lee, et al.. (2013). Benzimidazole-based antibacterial agents against Francisella tularensis. Bioorganic & Medicinal Chemistry. 21(11). 3318–3326. 35 indexed citations

17.

Awasthi, Divya, Kunal Kumar, Susan E. Knudson, Richard A. Slayden, & Iwao Ojima. (2013). SAR Studies on Trisubstituted Benzimidazoles as Inhibitors of Mtb FtsZ for the Development of Novel Antitubercular Agents. Journal of Medicinal Chemistry. 56(23). 9756–9770. 70 indexed citations

18.

Awasthi, Divya, Kunal Kumar, & Iwao Ojima. (2011). Therapeutic potential of FtsZ inhibition: a patent perspective. Expert Opinion on Therapeutic Patents. 21(5). 657–679. 48 indexed citations

19.

Kumar, Kunal, Divya Awasthi, Seung-Yub Lee, et al.. (2010). Novel Trisubstituted Benzimidazoles, Targeting Mtb FtsZ, as a New Class of Antitubercular Agents. Journal of Medicinal Chemistry. 54(1). 374–381. 152 indexed citations

20.

Kumar, Kunal, Divya Awasthi, William T. Berger, et al.. (2010). Discovery of Anti-TB Agents that Target the Cell-Division Protein FtsZ. Future Medicinal Chemistry. 2(8). 1305–1323. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact